An atlas of active enhancers across human cell types and tissues
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation. Using the FANTOM5 CAGE expression atlas, the authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify over 40,000 enhancer candidates from over 800 human cell and tissue samples across the whole human body. FANTOM5 (standing for functional annotation of the mammalian genome 5) is the fifth major stage of a major international collaboration that aims to dissect the transcriptional regulatory networks that define every human cell type. Two Articles in this issue of Nature present some of the project's latest results. The first paper uses the FANTOM5 panel of tissue and primary cell samples to define an atlas of active, in vivo bidirectionally transcribed enhancers across the human body. These authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify more than 40,000 enhancer candidates from over 800 human cell and tissue samples. The enhancer atlas is used to compare regulatory programs between different cell types and identify disease-associated regulatory SNPs, and will be a resource for studies on cell-type-specific enhancers. In the second paper, single-molecule sequencing is used to map human and mouse transcription start sites and their usage in a panel of distinct human and mouse primary cells, cell lines and tissues to produce the most comprehensive mammalian gene expression atlas to date. The data provide a plethora of insights into open reading frames and promoters across different cell types in addition to valuable annotation of mammalian cell-type-specific transcriptomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although enriched, histone modification and cofactor binding is not completely predictive of enhancer activity54,58,72,77,105.”
From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The majority of active enhancers are themselves transcribed, producing enhancer RNAs (eRNAs) in a bi-directional manner [73–77].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of their sequence properties, enhancers and promoters tend to differ in GC content, with many promoters and only a subset of enhancers containing CpG islands [74, 249].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“We filtered intragenic CAGE TCs with GG-initiation and those overlapping with coding exons and annotated enhancers24,70”
From Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes (2023) · cites this paper as [24]
In the citing paper
“as regulatory elements are subject to positive selection pressure, we identified sequences showing the highest conservation across mammalian species, including humans25–29.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Cited by
Items 301–400 of 1,017
DEEP: a general computational framework for predicting enhancers
Kleftogiannis, D., Kalnis, P., & Bajic, V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1058 · Cited by 125
“We used ‘genuine‘ enhancers recently published by the FANTOM5 consortium (27).”
MethodPearson, M. J., Philp, A. M., Heward, J. A., Roux, B. T., Walsh, D. A., Davis, E. T., Lindsay, M. A., & Jones, S. W. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39520 · Cited by 125
“Based on sequencing in ;400 human cell types including chondrocytes, the FANTOM project has recently released an atlas of 43,011 enhancer regions that are characterized by bidirectional transcription of singleexon efference RNAs (eRNAs) (31).”
BackgroundGrabundzija, I., Messing, S. A., Thomas, J., Cosby, R. L., Bilic, I., Miskey, C., Gogol-Döring, A., Kapitonov, V., Diem, T., Dalda, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10716 · Cited by 124
Characterization of noncoding regulatory DNA in the human genome
Elkon, R., & Agami, R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3863 · Cited by 148
Genome-wide prediction of cis-regulatory regions using supervised deep learning methods
Li, Y., Shi, W., & Wasserman, W. W. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2187-1 · Cited by 125
“The UK regions were sampled from the genome regions excluding all FANTOM CAGE tags, all exons, and DNaseI open regions.”
BackgroundMethodInfluentialEnhancer RNA profiling predicts transcription factor activity
Azofeifa, J. G., Allen, M. A., Hendrix, J., Read, T., Rubin, J. D., & Dowell, R. D. (2018) · Genome Research · doi:10.1101/gr.225755.117 · Cited by 127
“…are only beginning to be understood (Hah et al.2013; Li et al.2013; Sigova et al. 2015),theirpresenceis none-theless an indicator of enhancer activity (Andersson et al. 2014; Danko et al. 2015). eRNA detection requires extremely sensitive methods, both in the laboratory as well as computationally.”
MethodWu, T., Lyu, R., You, Q., & He, C. (2020) · Nature Methods · doi:10.1038/s41592-020-0797-9 · Cited by 123
Transcriptional cofactors display specificity for distinct types of core promoters
Haberle, V., Arnold, C. D., Pagani, M., Rath, M., Schernhuber, K., & Stark, A. (2019) · Nature · doi:10.1038/s41586-019-1210-7 · Cited by 123
Takahashi, K., Wang, F., Morita, K., Yan, Y., Hu, P. C., Zhao, P., Zhar, A. A., Wu, C., Gumbs, C. E., Little, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04924-z · Cited by 131
“4 Complex Inv16 Other Ph+ t((15;17) t(8;21) >67chr die(9;20) HeH iAMP21 No result t(12;21) t(1;19) Normal”
Ferreira, M. A. R., Gamazon, E. R., Al‐Ejeh, F., Aittomäki, K., Andrulis, I. L., Anton‐Culver, H., Arason, A., Arndt, V., Aronson, K. J., Arun, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08053-5 · Cited by 149
A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer
Chen, H., & Liang, H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.020 · Cited by 140
“However, the CAGE-defined enhancer annotation only covers a small fraction of eRNA loci ( 15,000) (Andersson et al., 2014; ENCODE Consortium, 2012).”
BackgroundMethodLauschke, V. M., Vorrink, S. U., Moro, S. M. L., Rezayee, F., Nordling, Å., Hendriks, D. F. G., Bell, C. C., Sison‐Young, R., Park, B. K., Goldring, C. E., et al. (2016) · Hepatology · doi:10.1002/hep.28780 · Cited by 121
“2B), possibly, at least in part, because of a positive correlation between the transcription of lncRNA and their proximal protein-coding genes.((27))”
BackgroundYu, N. Y.-L., Hallström, B. M., Fagerberg, L., Ponten, F., Kawaji, H., Carninci, P., Forrest, A. R. R., FANTOM Consortium, T., Hayashizaki, Y., Uhlén, M., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv608 · Cited by 119
“Developed by RIKEN in Japan, the cap analysis gene expression (CAGE) technology focuses on defining the promoter landscape, which is important for understanding gene regulation by transcription factors and enhancers (3–5).”
Self-citationCook, P. R., & Marenduzzo, D. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky763 · Cited by 120
“However, their molecular marks are so like those of their targets (68) that FANTOM5 now defines them solely as promoters firing to yield eRNAs (enhancer RNAs) rather than mRNAs (69).”
HACER: an atlas of human active enhancers to interpret regulatory variants
Wang, J., Dai, X., Berry, L. D., Cogan, J. D., Liu, Q., & Shyr, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky864 · Cited by 117
“Recently, the FANTOM5 project used expression correlation between eRNA and promoters to predict regulatory links (29).”
BackgroundMethodInfluentialTome, J. M., Tippens, N. D., & Lis, J. T. (2018) · Nature Genetics · doi:10.1038/s41588-018-0234-5 · Cited by 127
Single-Cell Epigenomics and Functional Fine-Mapping of Atherosclerosis GWAS Loci
Örd, T., Õunap, K., Stolze, L. K., Aherrahrou, R., Nurminen, V., Toropainen, A., Selvarajan, I., Lönnberg, T., Aavik, E., Ylä-Herttuala, S., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318971 · Cited by 119
Schreiber, J., Durham, T., Bilmes, J., & Noble, W. S. (2020) · Genome Biology · doi:10.1186/s13059-020-01977-6 · Cited by 118
Sammons, M. A., Zhu, J., Drake, A. M., & Berger, S. L. (2015) · Genome Research · doi:10.1101/gr.181883.114 · Cited by 119
“TP53 response element motifs are specifically and highly enriched in epithelial-specific enhancers, further supporting this notion (Andersson et al. 2014).”
Enhancer methylation dynamics contribute to cancer plasticity and patient mortality
Bell, R. E., Golan, T., Sheinboim, D., Malcov, H., Amar, D., Salamon, A., Liron, T., Gelfman, S., Gabet, Y., Shamir, R., et al. (2016) · Genome Research · doi:10.1101/gr.197194.115 · Cited by 117
“(D) (Top) Precision of eDMR-gene pair predictions is compared to predictions from CAGE (Andersson et al. 2014), IM-PET (Teng et al.”
InfluentialWang, X., Tucker, N. R., Rizki, G., Mills, R., Krijger, P. H., de Wit, E., Subramanian, V., Bartell, E., Nguyen, X.-X., Ye, J., et al. (2016) · eLife · doi:10.7554/elife.10557 · Cited by 117
“Moreover, QT/ QRS GWAS enhancers are enriched for DHS and Cap Analysis Gene Expression (CAGE) signals in human fetal heart, both of which are marks of greater enhancer activity (Figure 2) (Thurman et al., 2012; Andersson et al., 2014).”
Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo
Soccio, R. E., Chen, E. R., Rajapurkar, S. R., Safabakhsh, P., Marinis, J. M., Dispirito, J. R., Emmett, M. J., Briggs, E. R., Fang, B., Everett, L. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.025 · Cited by 117
“Overall, putative causal GWAS SNPs cluster more in promoters and enhancers than in exons (Andersson et al., 2014), and a recent effort to computationally identify causal GWAS SNPs for autoimmune diseases found that ~90% were non-coding, with ~60% in distal immune cell enhancers (Farh et al., 2015).”
In the loop: promoter–enhancer interactions and bioinformatics
Mora, A., Sandve, G. K., Gabrielsen, O. S., & Eskeland, R. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv097 · Cited by 116
“Recently, more methods have appeared: The FANTOM5 consortium introduced a method for finding all expression correlations for all promoter–enhancer pairs in a 500 kb window [77].”
BackgroundMethod7SK-BAF axis controls pervasive transcription at enhancers
Flynn, R. A., Do, B. T., Rubin, A. J., Calo, E., Lee, B., Kuchelmeister, H., Rale, M., Chu, C., Kool, E. T., Wysocka, J., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3176 · Cited by 115
King, A., Huang, K. Y., Rubbi, L., Liu, S., Wang, C., Wang, Y., Pellegrini, M. A., & Fan, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.083 · Cited by 133
Jiao, W., Chen, Y., Song, H., Li, D., Mei, H., Yang, F., Fang, E., Wang, X., Huang, K., Zheng, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0128-0 · Cited by 118
“Enhancers, the principle regulatory components of genome, contribute to the correct activation of gene promoter through forming chromosomal loops [6].”
BackgroundMethodSelf-citationRedefining the IBDs using genome-scale molecular phenotyping
Furey, T. S., Sethupathy, P., & Sheikh, S. Z. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0118-x · Cited by 129
NET-CAGE characterizes the dynamics and topology of human transcribed cis-regulatory elements
Hirabayashi, S., Bhagat, S., Matsuki, Y., Takegami, Y., Uehata, T., Kanemaru, A., Itoh, M., Shirakawa, K., Takaori‐Kondo, A., Takeuchi, O., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0485-9 · Cited by 117
Self-citationLam, D. D., de Souza, F. S. J., Nasif, S., Yamashita, M., López-Leal, R., Otero-Corchon, V., Meece, K., Sampath, H., Mercer, A. J., Wardlaw, S. L., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004935 · Cited by 115
“In recent years, genome-wide surveys have identified thousands of genomic regions with chromatin signatures indicative of potential enhancer activity[6,42], but the presence of chromatin marks or transgene assays are insufficient to conclusively assign regulatory functions to a particular genomic region, particularly…”
BackgroundResultIdentification of regulatory elements from nascent transcription using dREG
Wang, Z., Chu, T., Choate, L. A., & Danko, C. G. (2018) · Genome Research · doi:10.1101/gr.238279.118 · Cited by 136
“Active transcription initiation by Pol II has recently emerged as an alternative mark for the location of active regulatory elements (Andersson et al. 2014a; Core et al. 2014; Danko et al. 2015).”
BackgroundCondensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation
Li, W., Hu, Y., Oh, S., Ma, Q., Merkurjev, D., Song, X., Zhou, X., Liu, Z., Tanasa, B., He, X., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.002 · Cited by 114
Update of the FANTOM web resource: high resolution transcriptome of diverse cell types in mammals
Lizio, M., Harshbarger, J., Abugessaisa, I., Noguchi, S., Kondo, A., Severin, J., Mungall, C., Arenillas, D., Mathelier, A., Medvedeva, Y. A., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw995 · Cited by 115
“The main results of FANTOM5 were the most comprehensive promoter and enhancer atlases to date that could be generated using the same technology and the same platform (10,11).”
MethodSelf-citationYan, W., Chen, D., Schumacher, J., Durantini, D., Engelhorn, J., Chen, M., Carles, C. C., & Kaufmann, K. (2019) · Nature Communications · doi:10.1038/s41467-019-09513-2 · Cited by 133
Dogan, N., Wu, W., Morrissey, C. S., Chen, K.-B., Stonestrom, A., Long, M., Keller, C. A., Cheng, Y., Jain, D., Visel, A., et al. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0009-5 · Cited by 114
“Each of the 273 DNA segments were annotated by the presence or absence of ten features, specifically DHSs, binding by TAL1 or GATA1, or presence of H3K4me1, H3K4me3, H3K27ac, H3K27me3, or H3K9me3 (all in G1E-ER4 cells induced for 24 h with estradiol), binding by EP300 in MEL cells [46], or presence of CAGE (cap analys…”
BackgroundHaerty, W., & Ponting, C. P. (2015) · RNA · doi:10.1261/rna.047324.114 · Cited by 121
“We thus considered associations between lncRNA exonic GC content and the presence of TFBS or enhancer elements defined by the FANTOM5 consortium (Andersson et al. 2014) within these exons.”
BackgroundEnhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases
Murakawa, Y., Yoshihara, M., Kawaji, H., Nishikawa, M., Zayed, H., Suzuki, H., & Hayashizaki, Y. (2016) · Trends in Genetics · doi:10.1016/j.tig.2015.11.004 · Cited by 134
Self-citationPellacani, D., Bilenky, M., Kannan, N., Heravi-Moussavi, A., Knapp, D. J. H. F., Gakkhar, S., Moksa, M., Carles, A., Moore, R., Mungall, A. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.058 · Cited by 114
Isolation and genome-wide characterization of cellular DNA:RNA triplex structures
Cetin, N. S., Kuo, C., Ribarska, T., Li, R., Costa, I. G., & Grummt, I. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1305 · Cited by 125
“Transcription at intragenic enhancers attenuates expression of the host genes, the extent of attenuation positively correlating with transcription of eRNAs (52–55).”
Shoaib, M., Chen, Q., Shi, X., Nair, N., Prasanna, C., Yang, R., Walter, D., Frederiksen, K. S., Einarsson, H., Svensson, J. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25051-2 · Cited by 115
Non-coding RNAs, epigenetics, and cancer: tying it all together
Ferreira, H. J., & Esteller, M. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9715-8 · Cited by 128
Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
Klinge, C. M. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0548 · Cited by 115
“lncRNAs are defined as ncRNAs of >200 nucleotides that are transcribed by RNA pol II from regulatory regions including promoter upstream elements and technically include eRNAs (Andersson et al. 2014).”
BackgroundRegulatory variants: from detection to predicting impact
Rojano, E., Seoane, P., Ranea, J. A. G., & Perkins, J. R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby039 · Cited by 128
“Through Cap Analysis of Gene Expression (CAGE), a technology that captures short 5 0 ends of mRNA for producing short nucleotide sequences with NGS, they can determine genes, detect TSSs and recognize the activity of regulatory elements such as promoters, enhancers and others [85].”
BackgroundInoue, F., Kreimer, A., Ashuach, T., Ahituv, N., & Yosef, N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.09.010 · Cited by 111
“Several large-scalemapping efforts have characterized in a genome-widemanner the transcriptional and epigenetic landscape of hESC-derived NPCs or neural tissues and have annotated numerous genes and potential regulatory elements that could be important in neural differentiation (Andersson et al., 2014; Bernstein et al…”
BackgroundCarleton, J. B., Berrett, K. C., & Gertz, J. (2017) · Cell Systems · doi:10.1016/j.cels.2017.08.011 · Cited by 112
“Large-scale sequencing projects have now identified millions of TF-bound loci and potential enhancers within the human genome across hundreds of cell types (Andersson et al., 2014; Consortium, 2012; Roadmap Epigenomics et al., 2015).”
BackgroundRacko, D., Benedetti, F., Dorier, J., & Stasiak, A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1123 · Cited by 111
“Average size of eRNA is only of about 350 nt (43) but each round of its transcription, taking about 15 s (44), would be sufficient to inject more than 30 negative supercoils into transcribed chromatin fibre (44).”
BackgroundLong ncRNA expression associates with tissue-specific enhancers
Vučićević, D., Corradin, O., Ntini, E., Scacheri, P. C., & Ørom, U. A. (2015) · Cell Cycle · doi:10.4161/15384101.2014.977641 · Cited by 116
“Several studies have reported the involvement of long ncRNAs in mediating enhancer function.(3,4,9,13-18) One of the PreSTIGE predicted enhancers in K562 cells has previously been described to transcribe activating long ncRNAs ncRNAa3 and ncRNA-a4 regulating TAL1 and CMPK1 expression, respectively(3) (Fig.”
BackgroundMethodSelf-citationShared heritability and functional enrichment across six solid cancers
Jiang, X., Finucane, H. K., Schumacher, F. R., Schmit, S. L., Tyrer, J. P., Han, Y., Michailidou, K., Lesseur, C., Kuchenbaecker, K. B., Dennis, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08054-4 · Cited by 121
Predicting enhancers with deep convolutional neural networks
Min, X., Zeng, W., Chen, S., Chen, N., Chen, T., & Jiang, R. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1878-3 · Cited by 110
“With an experimental technique called CAGE (cap analysis of gene expression), FANTOM maps transcripts, transcription factors, promoters and enhancers that are active in a majority of mammalian primary cell lines [9, 35].”
MethodInfluentialEnhancer RNAs in cancer: regulation, mechanisms and therapeutic potential
Lee, J., Xiong, F., & Li, W. (2020) · RNA Biology · doi:10.1080/15476286.2020.1712895 · Cited by 120
“eRNAs with largely uncharted functions [4,16].”
BackgroundInfluentialSupervised enhancer prediction with epigenetic pattern recognition and targeted validation
Sethi, A., Gu, M., Gumusgoz, E., Chan, L., Yan, K.-K., Rozowsky, J., Barozzi, I., Afzal, V., Akiyama, J. A., Plajzer-Frick, I., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0907-8 · Cited by 109
“These validated enhancers were typically in conserved noncoding regions [9, 10] with particular patterns of chromatin [11], transcription factor (TF) binding [12], or noncoding transcription [13].”
A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression
Gallagher, M. D., Posavi, M., Huang, P., Unger, T. L., Berlyand, Y., Gruenewald, A. L., Chesi, A., Manduchi, E., Wells, A. D., Grant, S. F. A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.09.004 · Cited by 123
Sun, Y., & Chen, Y.-Q. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00945-8 · Cited by 121
“In contrast, most eRNAs are nonpolyadenylated transcripts that have shorter half-lives than polyadenylated lncRNAs and are difficult to discover according to their even lower levels in organisms [24, 106].”
BackgroundSelf-citationCancer whole-genome sequencing: present and future
Nakagawa, H., Wardell, C. P., Furuta, M., Taniguchi, H., & Fujimoto, A. (2015) · Oncogene · doi:10.1038/onc.2015.90 · Cited by 123
Long Non-coding RNA in Neuronal Development and Neurological Disorders
Li, L., Zhuang, Y., Zhao, X., & Li, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00744 · Cited by 107
Self-citationAustenaa, L. M. I., Barozzi, I., Simonatto, M., Masella, S., Chiara, G. D., Ghisletti, S., Curina, A., de Wit, E., Bouwman, B. A. M., de Pretis, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.018 · Cited by 116
Abugessaisa, I., Ramilowski, J. A., Lizio, M., Severin, J., Hasegawa, A., Harshbarger, J., Kondo, A., Noguchi, S., Yip, C. W., Ooi, J. L. C., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1054 · Cited by 106
“In the fifth edition of FANTOM (FANTOM5), we constructed ‘atlases’ of promoters (3,4), enhancers (5), miRNAs (6) and long non-coding RNAs (lncRNAs) (7) in several mammalian genomes.”
BackgroundSelf-citationZebley, C. C., Brown, C., Mi, T., Fan, Y., Alli, S., Boi, S., Galletti, G., Lugli, E., Langfitt, D., Metais, J.-Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110079 · Cited by 106
“Permutation test of enhancer overlap—The FANTOM5 (Andersson et al., 2014) phase 1 and 2 combined enhancer bed file for GRCh37 was used.”
MethodPrediction of histone post-translational modification patterns based on nascent transcription data
Wang, Z., Chivu, A. G., Choate, L. A., Rice, E. J., Miller, D. C., Chu, T., Chou, S.-P., Kingsley, N. B., Petersen, J. L., Finno, C. J., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01026-x · Cited by 105
The identification and functional annotation of RNA structures conserved in vertebrates
Seemann, S. E., Mirza, A. H., Hansen, C., Bang‐Berthelsen, C. H., Garde, C., Christensen‐Dalsgaard, M., Torarinsson, E., Yao, Z., Workman, C. T., Pociot, F., et al. (2017) · Genome Research · doi:10.1101/gr.208652.116 · Cited by 141
“( D , H ) Transcript stability at ENCODE HeLa DHSs, as described in Andersson et al. (2014b), and GC content of structured (CRS) and unstructured regions (no CRS).”
InfluentialEnhancers, enhancers – from their discovery to today’s universe of transcription enhancers
Schaffner, W. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0303 · Cited by 105
“Such transcripts, dubbed enhancer RNAs (eRNAs) (Kim et al., 2010; Andersson et al., 2014), can also include RNAs with a regulatory function (Orom and Shiekhattar, 2013).”
BackgroundCharacterization of the human RFX transcription factor family by regulatory and target gene analysis
Sugiaman‐Trapman, D., Vitezic, M., Jouhilahti, E., Mathelier, A., Lauter, G., Misra, S., Daub, C. O., Kere, J., & Swoboda, P. (2018) · BMC Genomics · doi:10.1186/s12864-018-4564-6 · Cited by 114
“We used search windows of − 5000 to + 2000 bp in relation to 30 RFX TSS locations and - 200 to + 200 bp around the midpoints of 13 significantly correlated candidate RFX enhancer sequences (extracted from Andersson et al. [49]; Table S7 in Additional file 3).”
MethodSelf-citationLi, Z., Li, X., Zhou, H., Gaynor, S. M., Selvaraj, M. S., Arapoglou, T., Quick, C., Liu, Y., Chen, H., Sun, R., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01640-x · Cited by 121
“24–26 .”
MethodTranscription imparts architecture, function and logic to enhancer units
Tippens, N. D., Liang, J., Leung, A. K.-Y., Wierbowski, S. D., Ozer, A., Booth, J. G., Lis, J. T., & Yu, H. (2020) · Nature Genetics · doi:10.1038/s41588-020-0686-2 · Cited by 103
Genome-wide analysis of somatic noncoding mutation patterns in cancer
Dietlein, F., Wang, A. B., Fagre, C. R., Tang, A., Besselink, N. J. M., Cuppen, E. P. J. G., Li, C., Sunyaev, S. R., Neal, J. T., & Allen, E. M. V. (2022) · Science · doi:10.1126/science.abg5601 · Cited by 123
Paradigm shifts in genomics through the FANTOM projects
de Hoon, M., Shin, J. W., & Carninci, P. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9593-8 · Cited by 101
“This led to the creation of a map of 44,000 active enhancers (Andersson et al. 2014).”
BackgroundSelf-citationModeling the relationship of epigenetic modifications to transcription factor binding
Liu, L., Jin, G., & Zhou, X. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv255 · Cited by 116
“Enhancers were defined by the FANTOM5 consortium (48).”
BackgroundInfluentialIdentification of altered cis-regulatory elements in human disease
Mathelier, A., Shi, W., & Wasserman, W. W. (2015) · Trends in Genetics · doi:10.1016/j.tig.2014.12.003 · Cited by 128
Xiong, L., Wu, F., Wu, Q., Xu, L., Cheung, O. K.-W., Kang, W., Mok, M. T. S., Szeto, L. L. M., Lun, C.-Y., Lung, R. W. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08245-z · Cited by 113
C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution
Kouno, T., Moody, J., Kwon, A. T.-J., Shibayama, Y., Kato, S., Huang, Y., Böttcher, M. E., Motakis, E., Mendez, M., Severin, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08126-5 · Cited by 116
Self-citationUniBind: maps of high-confidence direct TF-DNA interactions across nine species
Puig, R. R., Boddie, P., Khan, A., Castro-Mondragon, J. A., & Mathelier, A. (2021) · BMC Genomics · doi:10.1186/s12864-021-07760-6 · Cited by 101
STARR-seq — Principles and applications
Muerdter, F., Boryń, Ł. M., & Arnold, C. D. (2015) · Genomics · doi:10.1016/j.ygeno.2015.06.001 · Cited by 102
“In addition, enhancers can be bound and transcribed by RNA polymerase II, which gives rise to enhancer RNAs oreRNAs [26,27]andadditionallyareoftenfoundtobehypomethylated in mammaliancells [28,29].”
BackgroundSystematic analysis of intrinsic enhancer-promoter compatibility in the mouse genome
Martinez-Ara, M., Comoglio, F., van Arensbergen, J., & van Steensel, B. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.009 · Cited by 101
Co-regulation of paralog genes in the three-dimensional chromatin architecture
Ibn-Salem, J., Muro, E. M., & Andrade-Navarro, M. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw813 · Cited by 119
“Human enhancer annotations, including their genome locations and the corresponding genes they regulate, were obtained from the supplementary data of a recent CAGE analysis (24).”
MethodFeature Importance Ranking for Deep Learning
Wojtas, M., & Chen, K. (2020) · Research Explorer (The University of Manchester) · doi:10.48550/arxiv.2010.08973 · Cited by 202
“[15] B.”
BackgroundMethodInfluentialConvolutional neural networks (CNNs): concepts and applications in pharmacogenomics
Vaz, J. M., & Balaji, S. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10225-3 · Cited by 123
Baranasic, D., Hörtenhuber, M., Balwierz, P. J., Zehnder, T., Mukarram, A. K., Nepal, C., Várnai, C., Hadzhiev, Y., Jimenez-Gonzalez, A., Li, N., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01089-w · Cited by 101
Self-citationIntragenic Enhancers Attenuate Host Gene Expression
Cinghu, S., Yang, P., Kosak, J. P., Conway, A. E., Kumar, D., Oldfield, A. J., Adelman, K., & Jothi, R. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.010 · Cited by 100
“Although about half of all annotated enhancers are intragenic (Andersson et al., 2014; Kowalczyk et al., 2012; Shen et al., 2012; Whyte et al., 2013), most, if not all, studies of enhancer function were conducted by cloning the enhancer of interest, even if it is intragenic, either upstream or…”
Long Noncoding RNA Expression during Human B-Cell Development
Petri, A., Dybkær, K., Bøgsted, M., Thrue, C. A., Hagedorn, P., Schmitz, A., Bødker, J. S., Johnsen, H. E., & Kauppinen, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138236 · Cited by 113
Gawel, D. R., Serra-Musach, J., Lilja, S., Aagesen, J., Arenas, A., Asking, B., Bengnér, M., Björkander, J., Biggs, S., Ernerudh, J., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0657-3 · Cited by 98
RANKL-responsive epigenetic mechanism reprograms macrophages into bone-resorbing osteoclasts
Bae, S., Kim, K., Kang, K., Kim, H., Lee, M. J., Oh, B., Kaneko, K., Ma, S., Choi, J., Kwak, H., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00959-x · Cited by 108
Szczepińska, T., Kalisiak, K., Tomecki, R., Labno, A., Borowski, L. S., Kulinski, T. M., Adamska, D., Kosinska, J., & Dziembowski, A. (2015) · Genome Research · doi:10.1101/gr.189597.115 · Cited by 99
“The percentage of nucleotides covered by at least 100, 10, or 1 read was calculated. eRNA analysis We defined enhancers as 500 nt from the middle point on the forward strand and 500 nt from the middle point on the reverse strand from the list of 35,265 probable enhancers (Andersson et al. 2014).”
BackgroundMethodInfluentialKubo, N., Chen, P. B., Hu, R., Ye, Z., Sasaki, H., & Ren, B. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.02.030 · Cited by 118
Lu, Q., Powles, R. L., Abdallah, S., Ou, D., Wang, Q., Hu, Y., Lu, Y., Liu, W., Li, B., Mukherjee, S., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006933 · Cited by 97
“Pre-defined enhancer differentially expressed cell facets [17] were downloaded from”
Understanding Celiac Disease by Genomics
Withoff, S., Li, Y., Jonkers, I. H., & Wijmenga, C. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.02.003 · Cited by 108
Estill, M. S., Bolnick, J. M., Waterland, R. A., Bolnick, A. D., Diamond, M. P., & Krawetz, S. A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.006 · Cited by 99
Prediction of enhancer-promoter interactions via natural language processing
Zeng, W., Wu, M., & Jiang, R. (2018) · BMC Genomics · doi:10.1186/s12864-018-4459-6 · Cited by 96
“Recent studies have shown that noncoding single nucleotide polymorphisms (SNPs) that are associated with risk for numerous common diseases through genome-wide association studies (GWAS), frequently lie in cell line-specific enhancers [3, 4].”
BackgroundMethodInvestigating the Transcriptional Control of Cardiovascular Development
Kathiriya, I. S., Nora, E. P., & Bruneau, B. G. (2015) · Circulation Research · doi:10.1161/circresaha.116.302832 · Cited by 96
“Enhancers are more tissue-specific than promoters.(66) Although most enhancers are active in several related cell types, enhancer activation seems to be tightly linked with TFs that define cell-type identity.”
BackgroundBoyd, M., Thodberg, M., Vitezic, M., Bornholdt, J., Vitting-Seerup, K., Chen, Y., Coskun, M., Li, Y., Lo, B. Z. S., Klausen, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03766-z · Cited by 96
Self-citationChen, L., Fish, A. E., & Capra, J. A. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006484 · Cited by 95
Suntsova, M., & Buzdin, A. A. (2020) · BMC Genomics · doi:10.1186/s12864-020-06962-8 · Cited by 124
Xiong, F., Wang, R., Lee, J.-H., Li, S., Chen, S.-F., Liao, Z., Hasani, L. A., Nguyen, P. T.-M., Zhu, X., Krakowiak, J., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00515-8 · Cited by 112
Xu, Q., Georgiou, G., Frölich, S., van der Sande, M., Veenstra, G. J. C., Zhou, H., & van Heeringen, S. J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab598 · Cited by 95
Progress and challenges in bioinformatics approaches for enhancer identification
Kleftogiannis, D., Kalnis, P., & Bajić, V. B. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv101 · Cited by 110
“However, the largest obstacle stems from the limited knowledge about enhancer and mRNA promoter co-activity [40, 65].”
BackgroundMethodInfluentialSilla, T., Karadoulama, E., Mąkosa, D., Lubas, M., & Jensen, T. H. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.061 · Cited by 94
“This includes divergently transcribed enhancer RNAs (eRNAs) (Andersson et al., 2014; Djebali Cell This is an open access article under the CC BY-N et al., 2012) and so-called promoter upstream transcripts (PROMPTs)/upstream antisense (UA) RNAs (Preker et al., 2008; Seila et al., 2008).”
BackgroundSelf-citationDong, X., Liao, Z., Gritsch, D., Hadzhiev, Y., Bai, Y., Locascio, J. J., Guennewig, B., Liu, G., Blauwendraat, C., Wang, T., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0223-0 · Cited by 95
Self-citationDemystifying the secret mission of enhancers: linking distal regulatory elements to target genes
Yao, L., Berman, B. P., & Farnham, P. J. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1087961 · Cited by 93
“…have made public multiple methods using eQTL, DHS, histone modification, eRNA and DNA methylation to predict individual enhancer– gene linkages (Andersson et al., 2014; Aran et al., 2013; Corradin et al., 2014; Ernst et al., 2011; Li et al., 2013; Sheffield et al., 2013; Shen et al., 2012;…”
MethodRevealing a human p53 universe
Nguyen, T.-A. T., Grimm, S. A., Bushel, P. R., Li, J., Li, Y., Bennett, B. D., Lavender, C. A., Ward, J. M., Fargo, D. C., Anderson, C. W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky720 · Cited by 94
“In addition, 6820 (∼16%) of the ∼43 000 annotated active enhancers in the human genome (37) are within 5 kb of a p53 peak in ≥2 data sets (Supplementary Table ST5).”
BackgroundEpigenome engineering: new technologies for precision medicine
Sgro, A., & Blancafort, P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1000 · Cited by 99
“Several comprehensive public resources provide information on chromatin accessibility, nucleosome positioning, DNAme (presence of CpG islands), enhancers and super-enhancers (NIH Roadmap Epigenomics (211), ENCODE (212,213) and FANTOM5 (214,215) projects).”
BackgroundHogan, N. T., Whalen, M. B., Stolze, L. K., Hadeli, N. K., Lam, M. T., Springstead, J. R., Glass, C. K., & Romanoski, C. E. (2017) · eLife · doi:10.7554/elife.22536 · Cited by 94
“A major challenge is that mammalian genomes contain upwards of a million potential regulatory elements called enhancers, yet a given cell type only utilizes on the order of tens of thousands of active enhancers (ENCODE Project Consortium, 2012; Andersson et al., 2014).”
BackgroundRönnerblad, M., Andersson, R., Olofsson, T., Douagi, I., Karimi, M., Lehmann, S., Hoof, I., de Hoon, M., Itoh, M., Nagao-Sato, S., et al. (2014) · Blood · doi:10.1182/blood-2013-02-482893 · Cited by 93
Self-citation
Metadata
- Authors
- The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K., Schwarzfischer, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F. O., Jørgensen, M., Andersen, P. R., Bertin, N., Rackham, O., Burroughs, A. M., Baillie, J. K., Ishizu, Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C. J., Meehan, T. F., Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub, C. O., Heutink, P., Hume, D. A., Jensen, T. H., Suzuki, H., Hayashizaki, Y., Müller, F., Forrest, A. R. R., Carninci, P., Rehli, M., & Sandelin, A.
- Affiliations
- University of Copenhagen (DK)
- University Hospital Regensburg (DE)
- University of Birmingham (GB)
- University of North Carolina at Chapel Hill (US)
- RIKEN (JP)
- Aarhus University (DK)
- Roslin Institute (GB)
- European Bioinformatics Institute (GB)
- Karolinska Institutet (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- ORCID
- Andersson, Robin
- Gebhard, Claudia
- Miguel-Escalada, Irene
- Hoof, Ilka
- Bornholdt, Jette
- Chen, Yun
- Schmidl, Christian
- Suzuki, Takahiro
- Ntini, Evgenia
- Valen, Eivind
- Li, Kang
- Lilje, Berit
- Rapin, Nicolas
- Bagger, Frederik Otzen
- Andersen, Peter Refsing
- Bertin, Nicolas
- Rackham, Owen
- Burroughs, A. Maxwell
- Baillie, J. Kenneth
- Ishizu, Yuri
- Shimizu, Yuri
- Furuhata, Erina
- Meehan, Terrence F.
- Lassmann, Timo
- Itoh, Masayoshi
- Kawaji, Hideya
- Kawai, Jun
- Lennartsson, Andreas
- Daub, Carsten O.
- Heutink, Peter
- Hume, David A.
- Jensen, Torben Heick
- Suzuki, Harukazu
- Hayashizaki, Yoshihide
- Müller, Ferenc
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- Venue
- Nature
- Published
- 2014-03
- Volume
- 507
- Issue
- 7493
- Pages
- 455-461
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5215096
- OpenAlex
- W2015845481
- Cited by
- 2,550
- References
- 81
- Citations by year
- 2026: 93 · 2025: 140 · 2024: 207 · 2023: 185 · 2022: 225 · 2021: 280 · 2020: 232 · 2019: 226 · 2018: 261 · 2017: 208 · 2016: 186 · 2015: 212 · 2014: 89
- FWCI
- 95.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- SDL (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust (103258/Z/13/Z)
- European Commission (FP7/2007–2013/ERC, 2007–2013, FP7 2007-2013, FP7/2007)
- Deutsche Forschungsgemeinschaft (FP7/2007–2013)
- Ministry of Education, Culture, Sports, Science and Technology
- Lundbeckfonden (R167-2013-15058, R82-2010-6779)
- Novo Nordisk
- Novo Nordisk Fonden (NNF12OC0001211)
- H. Lundbeck A/S
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20251969, BB/I024801/1)
- Japan Society for the Promotion of Science (24659373, 25330333, 22228005)
- RIKEN
- National Institute of Dental and Craniofacial Research (R01DE022969)
- FP7 Ideas: European Research Council (204135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- enhancers, bidirectional transcription, unspliced RNA, FANTOM5, CAGE, cell type-specific gene regulation, regulatory single nucleotide polymorphisms, enhancer redundancy, transcription start sites, promoter usage, human cell types, tissue-specific enhancers
- MeSH terms
- Atlases as Topic, Cell Line, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, HeLa Cells, Humans, Organ Specificity, Promoter Regions, Genetic, RNA, Messenger, Cluster Analysis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Transcription Initiation Site, Molecular Sequence Annotation, Transcription Initiation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.